Valuation : PAVmed Inc.

Market Cap 29.23M 25.18M 23.85M 21.61M 40.55M 2.79B 40.75M 283M 109M 1.42B 110M 107M 4.49B P/E 2026 *
-1.15x
P/E 2027 * -2.11x
Enterprise Value 29.23M 25.18M 23.85M 21.61M 40.55M 2.79B 40.75M 283M 109M 1.42B 110M 107M 4.49B EV / Sales 2026 *
126x
EV / Sales 2027 * 48.7x
Free-Float
58.56%
Yield 2026 *
-
Yield 2027 * -
1 day-2.11%
1 week-20.83%
Current month-19.77%
1 month-0.71%
3 months-16.40%
6 months-59.81%
Current year-36.90%
1 week 4.11
Extreme 4.11
5.4
1 month 4.11
Extreme 4.11
5.65
Current year 3.85
Extreme 3.85
28.44
1 year 3.85
Extreme 3.85
28.44
3 years 3.85
Extreme 3.85
171
5 years 3.85
Extreme 3.85
4,365
10 years 3.85
Extreme 3.85
6,502.5
Manager TitleAgeSince
Compliance Officer 62 01/04/2023
Chief Executive Officer 60 26/06/2014
Director of Finance/CFO 68 01/03/2019
Director TitleAgeSince
Director/Board Member 60 01/10/2014
Chairman 60 26/06/2014
Director/Board Member 71 01/01/2015
Date Insider Type Main position Quantity % Market Cap. Importance
02/04/26 Free

Chief Technology Officer

70,000 1.0966%
02/04/26 Free

Chief Operating Officer

110,000 1.7233%
02/04/26 Free

Chief Executive Officer

350,000 5.4832%
Change 5-day change 1-year change 3-year change Capi.($)
-2.11%-20.83%-66.83%-97.61% 29.23M
+1.10%-0.65%+27.19%+19.34% 225B
-0.19%-3.62%+5.31%-19.41% 141B
+2.41%+0.67%-17.91%+22.42% 130B
-0.28%-10.08%-58.15%-19.54% 62.29B
-0.49%-1.97%-19.72%-15.81% 49.39B
-2.77%-6.15%+8.77%+14.99% 48.63B
+2.66%-2.61%+19.22%+30.28% 41.42B
+1.67%-0.25%+38.24%+56.84% 40.12B
-0.60%-4.41%-19.20%+46.52% 31.23B
Average +0.14%-5.16%-8.31%+3.80% 76.97B
Weighted average by Cap. +0.67%-2.50%+2.73%+10.74%

Financials

2026 *2027 *
Net sales 232K 200K 190K 172K 323K 22.21M 324K 2.25M 866K 11.3M 873K 854K 35.71M 600K 517K 489K 444K 832K 57.32M 837K 5.81M 2.24M 29.16M 2.25M 2.2M 92.15M
Net income -23.17M -19.97M -18.9M -17.14M -32.15M -2.21B -32.31M -225M -86.34M -1.13B -87.03M -85.12M -3.56B -20.15M -17.36M -16.44M -14.9M -27.95M -1.92B -28.09M -195M -75.07M -979M -75.67M -74.01M -3.09B
Net Debt - -
Logo PAVmed Inc.
PAVmed Inc. is a multi-product, commercial-stage medical technology company. The Company operates in the medical devices, diagnostics, and digital health sectors. Its subsidiary includes Lucid Diagnostics Inc., which is a commercial-stage cancer prevention medical diagnostics company that markets the EsoGuard Esophageal DNA Test and EsoCheck Esophageal Cell Collection Device for early detection of esophageal precancer to prevent esophageal cancer deaths. EsoCheck is a noninvasive swallowable balloon capsule catheter device capable of sampling surface esophageal cells. EsoGuard is a bisulfite-converted next-generation sequencing (NGS) DNA assay performed on surface esophageal cells collected with EsoCheck. Its other subsidiary, Veris Health Inc., is a digital health company focused on enhanced personalized cancer care through remote patient monitoring using implantable biologic sensors with wireless communication along with a custom suite of connected external devices.
Employees
41
Date Price Change Volume
11/09/26 $4.180 -2.11% 7,910
10/09/26 $4.270 -5.53% 23,917
09/09/26 $4.520 -4.24% 11,426
08/09/26 $4.720 -10.61% 98,945
04/09/26 $5.280 +3.73% 66,489
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
4.180USD
Average target price
36.50USD
Spread / Average Target
+773.21%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PAVM Stock
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!